Search Results - "Kverneland, Anders H"
-
1
Age and gender leucocytes variances and references values generated using the standardized ONE‐Study protocol
Published in Cytometry. Part A (01-06-2016)“…Flow cytometry is now accepted as an ideal technology to reveal changes in immune cell composition and function. However, it is also an error‐prone and…”
Get full text
Journal Article -
2
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab
Published in Oncoimmunology (04-05-2018)“…Introduction: Checkpoint inhibitors, including the CTLA-4 blocking antibody ipilimumab, have become the new standard therapy for many metastatic cancers…”
Get full text
Journal Article -
3
First in man study: Bcl-Xl_42-CAF ® 09b vaccines in patients with locally advanced prostate cancer
Published in Frontiers in immunology (14-03-2023)“…The B-cell lymphoma-extra-large (Bcl-XL) protein plays an important role in cancer cells' resistance to apoptosis. Pre-clinical studies have shown that…”
Get full text
Journal Article -
4
Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles
Published in Proteomics (Weinheim) (01-04-2023)“…Human plasma is a rich source of biomedical information and biomarkers. However, the enormous dynamic range of plasma proteins limits its accessibility to mass…”
Get full text
Journal Article -
5
Fully Automated Workflow for Integrated Sample Digestion and Evotip Loading Enabling High-Throughput Clinical Proteomics
Published in Molecular & cellular proteomics (01-07-2024)“…Protein identification and quantification is an important tool for biomarker discovery. With the increased sensitivity and speed of modern mass spectrometers,…”
Get full text
Journal Article -
6
Proteomics to study cancer immunity and improve treatment
Published in Seminars in immunopathology (01-03-2023)“…Cancer survival and progression depend on the ability of tumor cells to avoid immune recognition. Advances in the understanding of cancer immunity and tumor…”
Get full text
Journal Article -
7
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition
Published in Cytotherapy (Oxford, England) (01-08-2021)“…Lymphodepletion with non-myeloablative (NMA) chemotherapy is currently a prerequisite for adoptive cell therapy (ACT). ACT based on tumor-infiltrating…”
Get full text
Journal Article -
8
Abstract 1: Biomarkers of response and acquired resistance to TIL-ACT in solid tumors
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Background: Cancer immunotherapy has revolutionized cancer treatment in the last decade. However, most patients either do not respond to immunotherapy or…”
Get full text
Journal Article